11/14/2024
11:31 AM | 272 Capital LP (Filed by)
Harvard Bioscience (Subject)
| Form SC 13G/A | |
11/08/2024
3:45 PM | Harvard Bioscience (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:02 AM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
8:00 AM | Harvard Bioscience (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
7:29 AM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
4:01 PM | Harvard Bioscience (Filer)
| Form SD
Specialized Disclosure Report | |
05/14/2024
4:20 PM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
4:00 PM | Harvard Bioscience (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
6:00 AM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
3:51 PM | Harvard Bioscience (Filer)
| Form ARS | |
04/03/2024
7:01 AM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
4:00 PM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
12:02 PM | Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
| Form SC 13G | |
03/07/2024
6:00 AM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:46 AM | B. Riley Asset Management, LLC (Filed by)
Harvard Bioscience (Subject)
| Form SC 13G/A | |
01/26/2024
4:26 PM | BlackRock Inc. (Filed by)
Harvard Bioscience (Subject)
| Form SC 13G | |
01/22/2024
9:55 AM | Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
| Form SC 13G/A | |
01/05/2024
4:01 PM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
4:17 PM | Cote Jennifer (Reporting)
Harvard Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:18 PM | Green James W (Reporting)
Harvard Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
